UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Clinical trials for UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo shows promise in early sarcoma trial
Disease control OngoingThis early-phase study tests whether adding an experimental drug (BO-112) to the immunotherapy nivolumab before surgery can help treat soft tissue sarcoma. About 14 adults with removable tumors will receive the combination to check for side effects and immune changes. The goal is…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:15 UTC
-
Your own tumor cells could fight your cancer: new trial tests personalized T-Cell therapy
Disease control OngoingThis phase 2 trial tests a personalized cell therapy called LN-145 for people with certain advanced cancers (like ovarian, breast, thyroid, or bone cancers) that have not responded to treatment or have returned. The therapy uses a patient's own immune cells, taken from their tumo…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New combo therapy aims to shrink sarcomas before surgery
Disease control OngoingThis study looks at whether adding the drug pazopanib to standard radiation or chemoradiation helps shrink soft tissue sarcomas before they are removed surgically. About 140 adults and children with newly diagnosed, high-risk sarcomas that can be operated on are participating. Th…
Matched conditions: UNDIFFERENTIATED HIGH GRADE PLEOMORPHIC SARCOMA OF BONE
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC